Global Neurointerventional Device Market 2021 to 2030 Latest Industry Trends, Overview of Segments, New Technology and Growth Analysis

SDKI Inc. published a new report on "Global Neuro-Interventional Device Market-Forecast 2022-2030" This study includes the statistical and analytical approaches needed to grow the neurointerventional device market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-106112

The neurointerventional device market is estimated to reach US $ 5.00 billion by 2030 from a market value of US $ 2.92 billion in 2022 and is expected to grow at a CAGR of 8% during the 2022-2030 forecast period. I am.

Neurointerventional radiology or neurovascular surgery to treat vascular brain disease A relatively new specialist who uses minimally invasive intravascular technology. Treatment of disorders that occur in the spinal canals or arteries of the brain is neurointerventional. Neurointervention has gained great popularity among neurospecialists due to its advantageous function of reducing invasiveness. A wide range of patient target demographics, ongoing product creation and promotion, and attractive medical reimbursement are key drivers of growth in the neurointerventional device market. Growth in the medical system across the developing market and increased consumer demand for successful neurovascular products have also contributed to the growth of the neurointerventional device market during the forecast period.

In addition, key players in the global neurointerventional device market have adopted a variety of strategies to gain competitive advantage, including product launches, mergers and acquisitions, partnerships and agreements, investments and financing. doing. In July 2016, to build an OLIF (Oblique Lateral Interbody Fusion) model, Medtronic plc launched a Pivox oblique lateral spinal system with a lateral plate for the OLIF 25 and a Divergence-L anterior / oblique lumbar fusion system for the OLIF 51. Announced. For anterior column support, the OLIF platform is a minimally invasive spinal fusion procedure used to insert electrodes into the disc cavity.

However, strict regulations and a shortage of skilled neurosurgeons could curb the growth of the neurointerventional device market during the 2022-2030 forecast period.

Neurointerventional device market segment

The neurointerventional device market is by type (neurovascular thrombosis device, neurovascular stent, embolic protection device, intracapsular device, embolic coil, diversion device, liquid embolization, balloon, and stent recovery device. ), By technology (neurostomy, stent placement, coil embolization, cerebral angiography, blood flow disorders), by end user (hospital, outpatient surgery center), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview of

The neuro-interventional device market The neuro-interventional device market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

Report sample URL

https://www.sdki.jp/sample-request-106112

North America is the world's leading region in terms of market share. This is due to the growth of healthcare systems across the developing market and the growing consumer demand for successful neurovascular products. Meanwhile, the Asia Pacific neurointerventional device market is expected to show the highest growth rate / CAGR during the 2022-2030 forecast period. Factors such as a wide range of patient target demographics, ongoing product creation and promotion, and attractive medical reimbursement create favorable growth opportunities for the Asia Pacific neurointerventional device market.

Details of the survey report

https://www.sdki.jp/press-details/global-neuro-interventional-device-market/339

Key Players

The Neuro-Interventional Devices Market Key players in the Neuro-Interventional Devices Market include Medtronic, Stryker, iVascular SLU, Terumo Corporation, Boston Scientific Corporation, Merit Medical Systems, Penumbra, Inc., Rapid Medical. , MicroPort Scientific Corporation, InspireMD, Inc. and others. The survey includes a detailed competitive analysis of these key companies in the neurointerventional device market, company profiles, recent developments, and key market strategies.

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is to uncover market scenarios for different countries such as Japan, China, the United States, Canada, the United Kingdom and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.